The dangers of trade barriers in Europe's rollout - #TheAgenda with Stephen Cole
The Agenda • 1m 0s
Questions over efficacy, blood-clot fears, threats to block exports and sluggish supply - the distribution of vaccines has been causing major division across Europe, particularly between the EU and the UK. The European Commission President Ursula von der Leyen has said AstraZeneca must honour its contract with the bloc before exporting vaccines out of the EU – a move which could significantly impact the UK’s vaccine supply.
How will the disputes of today affect the vaccine procurement and future trade of tomorrow and beyond? The Agenda's Stephen Cole is joined by David Henig, Director of the UK Trade Policy Project who explains what he thinks the EU must do to emerge from the vaccines setback with strength and stability going forward.
Watch #TheAgenda in full and find out more at: https://www.cgtn.com/europe/the-agenda 📲
Follow CGTN Europe on social media and other platforms👇🏼
https://stories.cgtneurope.tv/follow-cgtn-europe/index.html
Up Next in The Agenda
-
Explainer: Europe's vaccine rift - #T...
Few events in time have called for an unapologetic effort of global cooperation more than the COVID-19 pandemic, yet many countries around the world have been treating ‘mission vaccination’ as a competition.
With vaccine nationalism, differing rollout strategies and political tensions afoot, Th...
-
The true cost of vaccine protectionis...
The Agenda's Stephen Cole is joined by Pieter Cleppe, Editor-in-chief of Brussels Report and Professor Lawrence Young, virologist & specialist in molecular oncology at the University of Warwick to discuss the potential pitfalls of prioritising competition over cooperation in the distribution ...
-
The Vaccine Rift - #TheAgenda with St...
Questions over efficacy, blood-clot fears, threats to block exports and sluggish supply - the distribution of vaccines has been causing major division across Europe, particularly between the EU and the UK. The European Commission President Ursula von der Leyen has said AstraZeneca must honour its...
